Alberta Investment Management Corp Galapagos Nv Transaction History

Alberta Investment Management Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$96.85 - $148.25 $7.51 Million - $11.5 Million	-77,588 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$185.52 - $231.25 $2.3 Million - $2.86 Million	12,375 Added 18.98%	77,588 $15.3 Million
Q1 2020 May 08, 2020	BUY	$143.0 - $274.03 $487,201 - $933,620	3,407 Added 5.51%	65,213 $12.8 Million
Q4 2019 Feb 14, 2020	SELL	$146.12 - $215.82 $259,363 - $383,080	-1,775 Reduced 2.79%	61,806 $12.8 Million
Q4 2018 Feb 14, 2019	SELL	$87.81 - $110.65 $1.67 Million - $2.1 Million	-19,000 Reduced 23.01%	63,581 $5.83 Million
Q3 2018 Nov 16, 2018	BUY	$90.63 - $120.22 $1.14 Million - $1.51 Million	12,581 Added 17.97%	82,581 $9.29 Million
Q3 2017 Nov 14, 2017	BUY	$73.17 - $103.47 $5.12 Million - $7.24 Million	70,000	70,000 $7.12 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

Stay updated on Alberta Investment Management Corp with notifications on news.